RUBY Trial Protocol OKO-210
A Phase 2, Multi-centre, randomised, double-masked, placebo-controlled study to evaluate the clinical safety and efficacy of OKG-0301 in the treatment of Acute Adenoviral Conjunctivitis.
https://clinicaltrials.gov/ct2/show/NCT03856645
For further information please contact the Clinical Trials Office on (08) 9381 0750 or email clinicalresearch@lei.org.au
